LOCOID
LOE ApproachingNDATOPICALCREAM
Approved
Mar 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 18h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LOCOID is a topical corticosteroid cream approved in 1982 for inflammatory skin conditions. The product is a small-molecule steroid formulation designed for localized dermatological treatment. It represents a mature, established therapeutic option in the topical corticosteroid class.
LOE Approaching
Product faces approaching loss of exclusivity with moderate competitive pressure (30%); expect contraction in team size and budget allocation.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Zero linked jobs indicate limited active hiring momentum for this product; career growth is constrained by LOE approaching status. Professionals should expect defensive commercial strategies and potential team restructuring rather than expansion opportunities.
Brand ManagerField Sales Representative
Worked on LOCOID at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.